As of May 9, 2025, the Stryker stock's PE ratio is 50.79. This results from the current EPS of $7.5 and stock price of $380.92. The P/E ratio has an increase of 19% from the past four quarters average of 42.8.
The PE ratio of Stryker has averaged 38.82 over the last ten years. The current PE ratio of 50.79 is 31% above the historical average. Over the past ten years, SYK's PE ratio was at its highest in the Mar 2021 quarter at 64.95, when the stock price was $243.58 and the EPS was $3.75. The lowest value was in the Dec 2018 quarter, when it reached 16.5 with a price of $156.75 and an EPS of $9.5.
Maximum annual increase: 145.52% in 2014
Maximum annual decrease: -70.91% in 2018
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | 45.81 | 27.57% | $360.05 | $7.86 |
2023 | 35.91 | -8.49% | $299.46 | $8.34 |
2022 | 39.24 | -22.37% | $244.49 | $6.23 |
2021 | 50.55 | -12.12% | $267.42 | $5.29 |
2020 | 57.52 | 52.61% | $245.04 | $4.26 |
2019 | 37.69 | 128.42% | $209.94 | $5.57 |
2018 | 16.5 | -70.91% | $156.75 | $9.5 |
2017 | 56.72 | 108.3% | $154.84 | $2.73 |
2016 | 27.23 | 11.92% | $119.81 | $4.4 |
2015 | 24.33 | -64.92% | $92.94 | $3.82 |
2014 | 69.36 | 145.52% | $94.33 | $1.36 |
2013 | 28.25 | 75.68% | $75.14 | $2.66 |
2012 | 16.08 | 12.61% | $54.82 | $3.41 |
2011 | 14.28 | -14.64% | $49.71 | $3.48 |
2010 | 16.73 | -7.31% | $53.7 | $3.21 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Mar 2025 | 49.63 | 8.34% | $372.25 | $7.5 |
Dec 2024 | 45.81 | 19.58% | $360.05 | $7.86 |
Sep 2024 | 38.31 | 2.13% | $361.26 | $9.43 |
Jun 2024 | 37.51 | -7.25% | $340.25 | $9.07 |
Mar 2024 | 40.44 | 12.61% | $357.87 | $8.85 |
Dec 2023 | 35.91 | -10.52% | $299.46 | $8.34 |
Sep 2023 | 40.13 | -5.95% | $273.27 | $6.81 |
Jun 2023 | 42.67 | 3.59% | $305.09 | $7.15 |
Mar 2023 | 41.19 | 4.97% | $285.47 | $6.93 |
Dec 2022 | 39.24 | 25.93% | $244.49 | $6.23 |
Sep 2022 | 31.16 | -13.68% | $202.54 | $6.5 |
Jun 2022 | 36.1 | -27.76% | $198.93 | $5.51 |
Mar 2022 | 49.97 | -1.15% | $267.35 | $5.35 |
Dec 2021 | 50.55 | -3.2% | $267.42 | $5.29 |
Sep 2021 | 52.22 | 11.39% | $263.72 | $5.05 |
Currently, SYK's PE ratio is greater than its 3, 5 and 10-year historical averages.
SYK's PE ratio is lower than its peer stock BSX, but it is greater than JNJ's and MDT's. Stryker is presently trading at a higher PE ratio (50.79) than its peer group average of 30.61.
Stock name | PE ratio | Market cap |
---|---|---|
EW Edwards Lifesciences Corp | 10.64 | $43.88B |
CNMD CONMED Corp | 15.82 | $1.88B |
JNJ Johnson & Johnson | 17.01 | $370.87B |
MDT Medtronic plc | 25.92 | $110.06B |
WAT Waters Corp | 33.15 | $21.82B |
GMED Globus Medical Inc | 43.39 | $7.99B |
SYK Stryker Corp | 51.74 | $148.31B |
BSX Boston Scientific Corp | 74.54 | $152.19B |
BAX Baxter International Inc | N/A | $16.36B |
IART Integra Lifesciences Holdings Corp | N/A | $1.06B |
SYK stock has a price to earnings ratio of 50.79 as of May 9, 2025.
The average PE ratio for SYK stock over the past 3 years is 39.84.
The average PE ratio for SYK stock over the past 5 years is 44.33.
Over the last ten years, the quarterly PE ratio reached a historic high of 64.95 in the Mar 2021 quarter.
SYK's price to earnings ratio is currently 31% above its 10-year historical average.
To determine the PE ratio, divide the most recent stock price by the TTM earnings per share (EPS). As of today (May 9, 2025), Stryker's stock price is $380.92. The earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $7.5. Therefore, Stryker's P/E ratio for today is 50.79. PE RATIO(50.79) = STOCK PRICE($380.92) / TTM EPS($7.5)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.